Great Lakes Advisors
CSII

Great Lakes Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Great Lakes Advisors’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,367
Closed -$257K – 759
2022
Q1 		$257K Buy
+11,367
New +$221K ﹤0.01% 632
2021
Q4 		– Sell
-11,409
Closed -$375K – 743
2021
Q3 		$375K Buy
11,409
+2,125
+23% +$79.3K 0.01% 561
2021
Q2 		$396K Buy
9,284
+606
+7% +$23.7K 0.01% 549
2021
Q1 		$333K Buy
8,678
+3,436
+66% +$146K 0.01% 560
2020
Q4 		$229K Buy
+5,242
New +$197K ﹤0.01% 586

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Great Lakes Advisors's CSII Position: Q2 2022 in Review

Great Lakes Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2022, closing a stake of 11,367 shares — an estimated $257K sold.

Great Lakes Advisors first reported a position in CSII in Q4 2020 and held it in 5 quarters. The position peaked at $396K in Q2 2021. 158 funds tracked by Wall St. Rank hold CSII as of Q2 2022.

  • Great Lakes Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q2 2022 after selling out during the quarter.
  • Great Lakes Advisors sold 11,367 Cardiovascular Systems, Inc. shares in Q2 2022, an estimated $257K.
  • Great Lakes Advisors first reported a position in Cardiovascular Systems, Inc. in Q4 2020 and held it in 5 quarters.
  • Great Lakes Advisors's Cardiovascular Systems, Inc. position peaked at $396K in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2022.

Based on Great Lakes Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.